Pfizer In Early-Stage Talks To Acquire Seagen - WSJ - News Summed Up

Pfizer In Early-Stage Talks To Acquire Seagen - WSJ


Financials (USD) Sales 2023 2 307 M - - Net income 2023 -571 M - - Net cash 2023 1 427 M - - P/E ratio 2023 -59,7x Yield 2023 - Capitalization 33 278 M 33 278 M - EV / Sales 2023 13,8x EV / Sales 2024 9,87x Nbr of Employees 3 256 Free-Float 98,3% Chart SEAGEN INC. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max. Period : Day Week Technical analysis trends SEAGEN INC. Short Term Mid-Term Long Term Trends Bullish Bullish Neutral Income Statement Evolution Please enable JavaScript in your browser's settings to use dynamic charts. Managers and Directors David R. Epstein Chief Executive Officer & Director Todd E. Simpson Chief Financial Officer Felix James Baker Chairman Vaughn B. Himes Chief Technical Officer Roger D. Dansey Chief Medical Officer Sector and Competitors 1st jan. Capi. (M$) SEAGEN INC. 25.57% 30 142


Source: Wall Street Journal February 27, 2023 04:16 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */